Design Therapeutics, Inc. (DSGN) Net Margin
- 2020-12-31: Net Margin -11681.82%.
- 2020-09-30: Net Margin -11600.00%.
- 2020-06-30: Net Margin -4651.61%.
- 2020-03-31: Net Margin -466.90%.
Complete source-backed net margin history.
- Available history
- 2020-03-31 to 2020-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2020-12-31 | -11681.82% |
| 2020-09-30 | -11600.00% |
| 2020-06-30 | -4651.61% |
| 2020-03-31 | -466.90% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2020-12-31 | -3663.72% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |